default author photo

Rutger Schepp

National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control

SCHOLARLY PAPERS

2

DOWNLOADS

256

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Serological Evidence for Reinfection with SARS-CoV-2; An Observational Cohort Study

Number of pages: 17 Posted: 08 Mar 2021
Robert Samuel van Binnendijk, Gerco den Hartog, Johan Reimerink, Rutger Schepp, Sabiena Feenstra, Daphne Reukers, Chantal Reusken, Dirk Eggink, Elisabeth A.M. Sanders, Titia Kortbeek and Harry Vennema
National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM) - WHO Reference Laboratory for COVID-19, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) and National Institute for Public Health and the Environment (RIVM)
Downloads 136 (537,489)

Abstract:

Loading...

2.

Frequency of RSV-Related COPD Exacerbations Using Standard and Enhanced Diagnostic Methods: A Binational Prospective Cohort Study

Number of pages: 30 Posted: 23 Jun 2023
Dexter James Wiseman, Ryan S. Thwaites, Andrew I. Ritchie, Lydia Finney, Mairi Macleod, Faisal Kamal, Hassan Shahbakhti, Lisa Van Smoorenburg, Huib A.M. Kerstjens, Joanne G. Wildenbeest, Deniz Oner, Jeroen Aerssens, Guy A. M. Berbers, Rutger Schepp, Ashley Uruchurtu, Ben Ditz, Louis Bont, James Allinson, Maarten van den Berge, Gavin C. Donaldson, Peter Openshaw, Jadwiga Wedzicha and RESCEU Investigators Group
Imperial College London - National Heart and Lung Institute (NHLI), Imperial College London - National Heart and Lung Institute (NHLI), Imperial College London - National Heart and Lung Institute (NHLI), Imperial College London - National Heart and Lung Institute (NHLI), Imperial College London - National Heart and Lung Institute (NHLI), Imperial College London - National Heart and Lung Institute (NHLI), Imperial College London - National Heart and Lung Institute (NHLI), University of Groningen - Groningen Research Institute for Asthma and COPD, University of Groningen - Groningen Research Institute for Asthma and COPD, Utrecht University - Department of Paediatric Infectious Diseases, Janssen Pharmaceutical K.K. - Infectious Diseases Translational Biomarkers, Janssen Pharmaceutical K.K. - Infectious Diseases Translational Biomarkers, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Imperial College London - National Heart and Lung Institute (NHLI), University of Groningen - Groningen Research Institute for Asthma and COPD, Utrecht University - Department of Pediatrics, Imperial College London - National Heart and Lung Institute (NHLI), University of Groningen - Groningen Research Institute for Asthma and COPD, Imperial College London - National Heart and Lung Institute (NHLI), Imperial College London - National Heart and Lung Institute (NHLI), Imperial College London - National Heart and Lung Institute (NHLI) and affiliation not provided to SSRN
Downloads 120 (596,393)

Abstract:

Loading...

RSV, Respiratory Syncytial Virus, COPD, Chronic Obstructive Pulmonary Disease, Exacerbation, Rhinovirus, Vaccine, Serology, PCR